- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/44 - Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 241/44
Total number of patents in this class: 507
10-year publication summary
|
32
|
40
|
28
|
36
|
18
|
21
|
32
|
27
|
20
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Neupharma, Inc. | 73 |
17 |
| Centre National de La Recherche Scientifique | 11010 |
15 |
| Vertex Pharmaceuticals Incorporated | 1586 |
15 |
| Institut Curie | 615 |
13 |
| Amgen Inc. | 4418 |
11 |
| Abivax | 119 |
11 |
| Merck Patent GmbH | 5725 |
9 |
| Universite de Montpellier | 1040 |
9 |
| Abbvie Inc. | 1844 |
8 |
| Purdue Pharma L.P. | 493 |
8 |
| Santen Pharmaceutical Co., Ltd. | 595 |
7 |
| Araxes Pharma LLC | 91 |
6 |
| BioEnergenix, LLC | 14 |
6 |
| Gilead Sciences, Inc. | 2219 |
6 |
| Kumiai Chemical Industry Co., Ltd. | 313 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 178 |
6 |
| The University of Queensland | 663 |
6 |
| BASF SE | 21313 |
5 |
| Takeda Pharmaceutical Company Limited | 2713 |
5 |
| Development Center for Biotechnology | 145 |
5 |
| Other owners | 333 |